D
Dina Morein
Researcher at Tel Aviv University
Publications - 8
Citations - 243
Dina Morein is an academic researcher from Tel Aviv University. The author has contributed to research in topics: CCL5 & Chemokine. The author has an hindex of 3, co-authored 6 publications receiving 112 citations.
Papers
More filters
Journal ArticleDOI
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Yulia Liubomirski,Shalom Lerrer,Tsipi Meshel,Linor Rubinstein-Achiasaf,Dina Morein,Stefan Wiemann,Cindy Körner,Adit Ben-Baruch +7 more
TL;DR: Novel tumor-stroma-inflammation networks that may promote TNBC aggressiveness by increasing the pro-malignancy potential of the TME and of the tumor cells themselves are identified, and key roles for CXCL8 are revealed in mediating these metastasis-promoting activities.
Journal ArticleDOI
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
TL;DR: The roles of chemokines and their receptors at atypical levels that are exerted on the cancer cell themselves are addressed: promoting tumor cell proliferation and survival; controlling tumor cell senescence; enriching tumors with cancer stem cells; inducing metastasis-related functions such as epithelial-to-mesenchymal transition (EMT) and elevated expression of matrix metalloproteinases (MMPs).
Journal ArticleDOI
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Yulia Liubomirski,Shalom Lerrer,Tsipi Meshel,Dina Morein,Linor Rubinstein-Achiasaf,David Sprinzak,Stefan Wiemann,Cindy Körner,Marcelo Ehrlich,Adit Ben-Baruch +9 more
TL;DR: DAPT, inhibitor of γ-secretase that participates in activation of Notch receptors, inhibited the migration and invasion of TNBC cells that were grown in “Contact” co-cultures with MSCs or with patient-derived cancer-associated fibroblasts (CAFs), in the presence of TNFα.
Journal ArticleDOI
Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells.
Linor Rubinstein-Achiasaf,Dina Morein,Hagar Ben-Yaakov,Yulia Liubomirski,Tsipi Meshel,Eti Elbaz,Orly Dorot,Edward Pichinuk,Michael Gershovits,Miguel Weil,Adit Ben-Baruch +10 more
TL;DR: In this article, the impact of consistent inflammatory stimulation on stromal cell plasticity was determined, showing that chronic inflammation can induce mesenchymal stem cells (MSCs) to undergo conversion at the tumor site to cancer-associated fibroblasts (CAFs), which are generally connected to enhanced tumor progression.
Journal ArticleDOI
Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes
TL;DR: Over-expressed WT-PD-L1 in human TNBC cells and in luminal-A breast cancer cells demonstrated that cell-autonomous PD-L 1 activities lead to increased tumor cell growth, invasion and release of pro-metastatic factors, which were promoted by PD-1 and were inhibited by mutating S283 in PD- L1.